Carolyn Magill has over 20 years of leadership experience in healthcare, with a focus on the transition from fee-for-service to value-based care. As the CEO of Aetion, she provides real-world analytics and evidence to guide crucial healthcare decisions, including which treatments are most effective for specific individuals and when. Previously, Magill held leadership positions at notable companies involved in the shift from volume to value, such as UnitedHealth Group, Evolent, and Remedy Partners. She also serves on the board of the Center for Health Policy Development and Parity, an organization dedicated to achieving gender equality in senior management and board positions.
Read More
Read More